The AACT promotes and unites scientists and clinicians in the advancement of research, education and treatment of diseases caused by chemicals, drugs and toxins. AACT provides support through research awards and grant programs in all stages of one’s career.
The AACT Research awards are designed to stimulate interest in research by members of the AACT as well as their trainees. The goal of the AACT research awards program is to provide competitive funding for research that encourages the development of new therapies and treatment and adds to the understanding of the principles and practice of clinical toxicology. The intended research projects should advance the mission of the AACT to unite “scientists and clinicians in the advancement of research, education, prevention and treatment of diseases caused by chemicals, drugs and toxins.”
The awards encompass a number of styles, including individual small grants to senior investigators or to toxicology trainees to study specific topics, larger grants to clinical toxicologists that are in the early stage of their careers, and travel grants so that students and trainees can present their research at the NACCT meeting. The mentoring of trainees by more experienced senior investigators is a key aspect of certain awards
AACT supports the professional growth and development of young clinicians by supporting projects through our grants program. Student and Trainee travel awards are also available to support travel to NACCT.
Several different types of awards and grant programs exist. Specific information is available for each program on the right.
Past AACT Student and Trainee Travel Award Recipients
Eric McGillis, MD, BSc
2018 Recipient
Regions Hospital
“Rapid-onset hyperthermia and hypercapnea preceding rigor mortis and cardiopulmonary arrest in a DNP overdose” and “Lack of seizures in patients presenting to the ED with suspected benzodiazepine toxicity”
Paulius Mui
2018 Recipient
Virginia Commonwealth University School of Medicine
“Impact of healthcare resources on intentional and unintentional toxic exposures in urban and rural communities”
Daniel Nogee, MD
2018 Recipient
Yale New Haven Hospital
“Development of a prototype software tool to assist with toxidrome recognition”
Past AACT Gary S. Wasserman Memorial Pediatric Abstract Award Recipients
Emily Winograd, PharmD
2018 Recipient
Florida Poison Information Center – Jacksonville
“Pediatric guanfacine exposures reported to the National Poison Data System, 2000 – 2016”
Christopher Gaw, MD, MBE
2017 Recipient
Children’s Hospital of Philadelphia
“Evaluation of Dose and Outcomes from Pediatric Vilazodone Ingestions”
Past AACT Research Grant Award Recipients
Morgan Riggan, MD
2017 Recipient
New York University and Bellevue Hospital, New York City Poison Control Center
“The effects of activated charcoal and polyethylene glycol with electrolyte solution on bupropion XL concentration in vitro”
Past AACT Toxicology Trainee Research Grant
Bryan Stierman MD, MPH
2018 Recipient
Boston Children’s Hospital
“Neurodevelopmental Effects of Prenatal Manganese Exposure”
Sean Boley, MD
2016 Recipient
Hennepin County Medical Cente
“A prospective analysis of physostigmine use versus standard care in the treatment of anticholinergic toxicity”
JoAn R. Laes, MD
2014 Recipient
HealthPartners Institute for Education and Research
“Toxicology Education in Emergency Medicine: A Formal Needs Assessment and Pilot Study”
Past AACT Junior Investigator Award
Patrick C. Ng, MD
2018 Recipient
Denver Health and Hospital Authority
“Novel Oral Countermeasures for Acute Oral Cyanide Poisoning“
George Sam Wang, MD
2016 Recipient
University of Colorado Anschutz Medical Campus
“Physostigmine vs. Lorazepam for Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome“
Jon B. Cole, MD
2013 Recipient
Hennepin County Medical Center
“A randomized double blind controlled study comparing haloperidol to ketamine as a chemical restraint for “severe agitation“
David H. Jang, MD
2011 Recipient
New York University School of Medicine
“Methylene blue in an experimental model of severe shock from calcium channel blocker poisoning“
Past AACT Lampe-Kunkel Memorial Award
2005 Award Winners
Study Title: Mycotoxins and Toxigenic Fungi in the Outdoor Environment
PI: Daniel Sudakin, M.D.
Institution: Oregon State University
Grant Amount: $2,250
Study Title: Assessment of Charcoal Adsorption of Botulinum Toxin
PI: Robert Hoffman, M.D.
Institution: Beth Israel Medical Center
Grant Amount: $1827
2007 Award Winner
Study Title: Cross-reactivity of False Hellebore Steroid Alkaloid Compounds with a Digoxin Clinical Chemistry Assay
PI: Laura K. Bechtel, Ph.D.
Institution: University of Virginia
Grant Amount: $1,500
2012 Award Winner
Study Title: Lily of the Valley Ingestion: Epidemiology, Laboratory Diagnosis and Treatment of Convallaria Toxicity
PI: Asim Tarabar, MD and Thomas Robey, MD
Institution: Yale School of Medicine
Grant Amount: $3,750
2014 Award Winner
Study Title: Ginkgo Biloba and Panax Ginseng’s effects on driving compared to placebo: a pilot study
PI: Michael Greenberg, MD
Institution: Drexel University
Grant Amount: $3,750
2016 Award Winner
Study Title: Physostigmine vs. lorazepam for treatment of adolescent antimuscarinic (anticholinergic) toxidrome
PI: George Sam Wang, MD
Institution: University of Colorado Denver
Grant Amount: $44,894